Replies to post #15344 on Marker Therapeutics Inc (MRKR)

[tpizzazz24]

No. This is the open label study run to mirror 280 pt Mayo P2 blind study. This, according to PR's and statements made by company. In order to provide data as the study progresses that Mayo may not be able to. So the company shoukd have an idea of how the big study is going before any data is released by Mayo.